The Medical Imaging Diagnosis segmentation by application delineates five primary clinical domains that collectively drive market demand. Oncology accounts for the largest share (approximately 35%), reflecting intensive use of PET, CT, and MRI for tumor detection, staging, and treatment monitoring, which commands premium pricing and high scan volumes. Cardiology follows with around 25% of revenue, powered by coronary CT angiography, cardiac MRI, and stress echocardiography that support both diagnostic and interventional pathways. Neurology contributes roughly 20%, as MRI and CT are indispensable for stroke assessment, neurodegenerative disease evaluation, and surgical planning. Orthopedics holds about 15% of the market, leveraging X‑ray, CT, and MRI to assess fractures, joint degeneration, and pre‑operative planning. The residual 5% labeled Other Clinical Areas includes veterinary imaging, ophthalmology, and emerging fields such as radiomics, each adding niche but growing revenue streams. These application shares are directly reflected in the accompanying pie‑chart, illustrating how clinical utilization patterns shape the overall market size.